Ozempic users are consuming fewer calories, and as a result are buying smaller sizes to fit their newly svelte bodies or, in ...

The FDA approved dapagliflozin (Farxiga) for glycemic control in children ages 10 years and older with type 2 diabetes, based ...

The impact of type 2 diabetes and weight loss drugs like Novo Nordisk's (NVO) Ozempic and Wegovy and Eli Lilly's (LLY) ...

With GLP-1s, providers must always be prepared for patients being forced to stop a medication due to factors beyond the ...

New research has found that for people with extreme obesity taking GLP-1 drugs like Ozempic or Wegovy before bariatric ...

Drucker of Lunenfeld-Tanenbaum Research Institute, University of Toronto, evaluated the efficacy and safety of glucagon-like ...

Barnstorming GLP-1 drugs have sent Eli Lilly and Novo Nordisk rocketing up the list of the most valuable pharma brands. The ...

Ozempic, Wegovy and other GLP-1 medications could help extremely obese patients drop enough pounds to be eligible for ...

Bariatric metabolic surgery (BMS) offers a survival advantage over glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in adults with obesity and diabetes for ≤ 10 years, which may be explained by ...

GLP-1 agonist prescriptions rose by nearly 600% among adolescents and young adults in the United States between 2020 and 2023.

Folks using a weight-loss drugs like Ozempic, Wegovy or Zepbound still have nutritional requirements for good health, even if ...